FDA Alerts Archive for 2012
January 9, 2012
- Endo Pharmaceuticals Opiate Products by Novartis Consumer Health: Public Health Advisory - Potential Safety Risk
- Novartis Consumer Health Over-The-Counter Products: Recall - Potential Presence of Foreign Tablets or Chipped or Broken Tablets or Gelcaps
January 12, 2012
- Bedford Laboratories Polymyxin B For Injection USP And Vecuronium Bromide For Injection: Recall - Glass Particles
- CardioGen-82 PET Scan: Drug Safety Communication - Increased Radiation Exposure
January 13, 2012
January 20, 2012
- Tysabri (natalizumab): Drug Safety Communication - New Risk Factor for Progressive Multifocal Leukoencephalopathy (PML)
- Perfect Image Solutions Topical Hair Regrowth Products: Recall - Unapproved Drugs, Risk of Health Hazards
- Vagifresh Ball, Vagifresh Gel, Female One: Recall - Undeclared Drug Ingredient, Bacterial Contamination
January 30, 2012
February 1, 2012
February 3, 2012
- Gris-PEG (griseofulvin ultramicrosize): Health Advisory - Risk of Product Mix-Up
- Acetylcysteine Solution, USP (Roxane Laboratories, Inc.): Recall - Visible Glass Particle
February 6, 2012
February 8, 2012
- Proton Pump Inhibitors (PPIs) - Drug Safety Communication: Clostridium Difficile-Associated Diarrhea (CDAD) Can be Associated With Stomach Acid Drugs
- H & P Industries Povidone Iodine Prep Pads: Recall - Potential Microbial Contamination
February 9, 2012
February 10, 2012
February 13, 2012
February 14, 2012
February 17, 2012
February 22, 2012
February 23, 2012
- American Regent Injectable Products: Recall - Visible Particulates in Products
- Cytarabine for Injection, 1 gm/vial [Bedford Labs]: Recall: Risk of Lack of Sterility
February 27, 2012
- Regenerect: Recall - Undeclared Drug Ingredient
- Norgestimate and Ethinyl Estradiol Tablets: Recall - Packaging Error, Potential for Incorrect Dosing Regimen
February 28, 2012
March 1, 2012
March 16, 2012
March 19, 2012
March 21, 2012
March 23, 2012
March 28, 2012
April 3, 2012
April 10, 2012
April 18, 2012
April 20, 2012
- Brilliant Blue G Compounded by Franck's: Recall of Unapproved Drug - Ongoing Investigation of Fungal Endophthalmitis Cases
- Certain Compounded Drugs from Franck's: FDA Issues Second Warning to Physicians
- Aliskiren-containing Medications: Drug Safety Comunication - New Warning and Contraindication
April 25, 2012
April 26, 2012
May 4, 2012
May 7, 2012
May 14, 2012
- Gilenya (fingolimod): Drug Safety Communication - Safety Review of a Reported Death After the First Dose
- Hydromorphone Hydrochloride Injection 1 MG/ML, (C-II) 1 ML Fill In 2.5 ML Carpuject: Recall - May Contain More Than the Intended Fill Volume
May 17, 2012
May 21, 2012
May 23, 2012
May 24, 2012
May 25, 2012
May 29, 2012
May 30, 2012
June 1, 2012
June 6, 2012
June 7, 2012
June 26, 2012
June 27, 2012
June 29, 2012
- Ondansetron (Zofran) IV: Drug Safety Communication - QT prolongation
- Vecuronium Bromide For Injection Preservative Free (Bedford Laboratories): Recall - Particulate Matter
- Cataplex ACP, Cataplex C, and Pancreatrophin PMG Dietary Supplements: Recall - Potential for Contamination With Salmonella
July 6, 2012
July 10, 2012
July 16, 2012
July 23, 2012
August 1, 2012
August 15, 2012
August 16, 2012
- Hospira Propofol Injectable Emulsion: Recall - Glass Vial Defect
- Hospira Hydromorphone Hydrochloride Injection 2 MG/ML, 1 mL fill in 2.5 mL Carpuject: Recall- May Contain More Than The Intended Fill Volume
August 21, 2012
August 30, 2012
August 31, 2012
September 5, 2012
September 11, 2012
September 13, 2012
September 18, 2012
- Intestinomicina (contains chloramphenicol) by Laboratorios Lopez: Safety Alert - Contains Drug Ingredient Withdrawn from US
- SimplyThick: Public Health Notification - Risk of Life-Threatening Bowel Condition
- ACTRA-Sx 500 Capsules by Body Basics Inc.: Recall - Undeclared Drug Ingredient
September 19, 2012
September 21, 2012
September 24, 2012
September 25, 2012
October 5, 2012
October 6, 2012
- New England Compounding Center (NECC) Potentially Contaminated Medication: Fungal Meningitis Outbreak
- Hospira Lactated Ringer's And 5% Dextrose Injection, 1000 Ml, Flexible Containers: Recall - Mold Contamination
October 15, 2012
October 16, 2012
October 22, 2012
October 24, 2012
October 25, 2012
October 31, 2012
- Classic Zi Xiu Tang Bee Pollen Capsules And Ultimate Formula Capsules by Zi Xiu Tang Success: Recall - Undeclared Sibutramine
- Ameridose, LLC: Recall of Unexpired Products in Circulation
November 1, 2012
November 2, 2012
November 28, 2012
- Atorvastatin Calcium Tablets by Ranbaxy Inc.: Recall - Presence of Foreign Substance
- Isovue (iopamidol injection) Pre-Filled Power Injector Syringes by Bracco Diagnostics Inc.: Recall - Presence of Particulates
December 4, 2012
December 6, 2012
December 7, 2012
- Qualitest Hydrocodone Bitartrate and Acetaminophen Tablets 10 mg/500 mg: Recall - Potential for Oversized Tablets
- Protandim by LifeVantage Corporation: Recall - Possible Metal Fragments in Product
December 12, 2012
December 15, 2012
December 17, 2012
December 18, 2012
December 19, 2012
- Reumofan Plus Dietary Supplement Relabeled and Sold as “WOW”: Public Warning - Undeclared Drug Ingredients
- Pradaxa (dabigatran etexilate mesylate): Drug Safety Communication - Should Not Be Used in Patients with Mechanical Prosthetic Heart Valves
- Incivek (telaprevir) In Combination with Drugs Peginterferon Alfa and Ribavirin (Incivek combination treatment): Drug Safety Communication - Serious Skin Reactions
- Zicam Extreme Congestion Relief Nasal Gel: Recall - Contamination With Burkholderia Cepacia
December 21, 2012
FDA Alerts archive
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.